Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shenon Sethi
Institution:
Memorial Sloan Kettering Cancer Center
Observed institutions:
Rush University Medical Center,
Memorial Sloan Kettering Cancer Center
ORCID:
0000-0002-0751-0615
Observed ORCID:
0000-0002-0751-0615
OpenAlex ID:
A5018066747
POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC
2022
·
Marina K. Baine
, Christopher A. Febres-Aldana
, et al.
·
Journal of Thoracic Oncology
·
94
PDF
CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience
2022
·
M Lia Palomba
, David Qualls
, et al.
·
Journal for ImmunoTherapy of Cancer
·
37
PDF
Clinicopathologic Characteristics of Young Patients with Oral Squamous Cell Carcinoma
2021
·
Wadad S. Mneimneh
, Bin Xu
, et al.
·
Head and Neck Pathology
·
37
Umbilical Lesions: Clinicopathologic Features of 99 Tumors
2018
·
Lei Yan
, Shenon Sethi
, et al.
·
International Journal of Surgical Pathology
·
20
Plasma cell myeloma with anaplastic transformation
2016
·
Shenon Sethi
, Ira Miller
·
Blood
·
18
Biphenotypic sinonasal sarcoma: Report of 3 cases with a review of literature
2021
·
Shenon Sethi
, Brittany Cody
, et al.
·
Human Pathology Case Reports
·
16
Cytologic and clinical features of NIFTP: Can we diagnose based on preoperative fine‐needle aspiration
2019
·
Lei Yan
, Shenon Sethi
, et al.
·
Diagnostic Cytopathology
·
15
Current Knowledge in Genetics, Molecular Diagnostic Tools, and Treatments for Mantle Cell Lymphomas
2021
·
Shenon Sethi
, Zachary Epstein-Peterson
, et al.
·
Frontiers in Oncology
·
14
PDF
Primary Well-Differentiated Neuroendocrine Tumor/Carcinoid of the Prostate: Case Report and Review of Literature
2024
·
Mohamed Alhamar
, Shenon Sethi
, et al.
·
International Journal of Surgical Pathology
·
5
PDF
Proteogenomic Profiling of High-Grade B-Cell Lymphoma With 11q Aberrations and Burkitt Lymphoma Reveals Lymphoid Enhancer Binding Factor 1 as a Novel Biomarker
2023
·
Stephanie N. Hurwitz
, Brian Lockhart
, et al.
·
Modern Pathology
·
5
PDF
Mycobacterium Spindle Cell Pseudotumor Caused by Mycobacterium xenopi : A First Described Association of a Rare Entity Presenting in the Lung
2019
·
Karina Furlan
, Prih Rohra
, et al.
·
International Journal of Surgical Pathology
·
4
Polytypic B cells, monotypic/monoclonal B-cell proliferations, and neoplastic T cells diverge from TET2-/DNMT3A-mutant clonal hematopoiesis in follicular helper T-cell lymphomas
2024
·
Natasha E. Lewis
, Kseniya Petrova-Drus
, et al.
·
Haematologica
·
3
Light Chain Amyloidosis Presenting as Bilateral External Auditory Canal Obstructing Masses
2018
·
Shenon Sethi
, Agne Paner
, et al.
·
Otology & Neurotology
·
3
A Novel Complication of the Dall-Miles Cable Grip System Mimicking Recurrent Synovial Chondromatosis
2016
·
Jacob Wilson
, Andrew J. Riff
, et al.
·
JBJS Case Connector
·
3
Correlation between TP53 mutational status and digital quantification of p53 immunohistochemistry in mantle cell lymphoma
2025
·
Mingfei Yan
, Shenon Sethi
, et al.
·
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
·
2
SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
·
Cancer Discovery
·
1
PDF
Leukemic presentation in nodal mantle cell lymphoma is characterized by frequent SOX11 negativity, a poor risk genomic landscape including higher TP53 alterations, and worse overall survival
2025
·
Mingfei Yan
, Shenon Sethi
, et al.
·
Haematologica
·
1
Genomic Characterization and Classification of BCL6 Rearranged Follicular Lymphomas
2024
·
Anu Amallraja
, Gunes Gundem
, et al.
·
Blood
·
1
Supplementary Table 3 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S4 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S5 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Table 4 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S6 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S2 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Show more works
View as search
Works count:
58
Citation count:
278
H-index:
8
I10-index:
8
Year
Topic
Type